Oral ketamine vs placebo in patients with cancer-related neuropathic pain
Ketamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited.1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the population studied did not specifically have neuropat...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American Medical Association
2018
|
| Online Access: | https://eprints.nottingham.ac.uk/51161/ |
| _version_ | 1848798431857868800 |
|---|---|
| author | Fallon, Marie T. Wilcock, Andrew Kelly, Caroline A. Paul, James Lewsley, Liz-Anne Norrie, John Laird, Barry J. A. |
| author_facet | Fallon, Marie T. Wilcock, Andrew Kelly, Caroline A. Paul, James Lewsley, Liz-Anne Norrie, John Laird, Barry J. A. |
| author_sort | Fallon, Marie T. |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Ketamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited.1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the population studied did not specifically have neuropathic pain. A randomized trial of oral ketamine for cancer-related neuropathic pain has been called for, and the present trial addresses that need. |
| first_indexed | 2025-11-14T20:19:40Z |
| format | Article |
| id | nottingham-51161 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| language | English |
| last_indexed | 2025-11-14T20:19:40Z |
| publishDate | 2018 |
| publisher | American Medical Association |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-511612018-04-17T04:27:49Z https://eprints.nottingham.ac.uk/51161/ Oral ketamine vs placebo in patients with cancer-related neuropathic pain Fallon, Marie T. Wilcock, Andrew Kelly, Caroline A. Paul, James Lewsley, Liz-Anne Norrie, John Laird, Barry J. A. Ketamine hydrochloride is used as an adjuvant treatment for cancer-related neuropathic pain, but evidence of its effectiveness is limited.1 Findings of a large trial investigating the use of ketamine for general cancer pain were negative, but the population studied did not specifically have neuropathic pain. A randomized trial of oral ketamine for cancer-related neuropathic pain has been called for, and the present trial addresses that need. American Medical Association 2018-04-05 Article PeerReviewed application/pdf en cc_by https://eprints.nottingham.ac.uk/51161/1/jamaoncology_Fallon_2018_ld_180004.pdf Fallon, Marie T., Wilcock, Andrew, Kelly, Caroline A., Paul, James, Lewsley, Liz-Anne, Norrie, John and Laird, Barry J. A. (2018) Oral ketamine vs placebo in patients with cancer-related neuropathic pain. JAMA Oncology . ISSN 2374-2437 https://doi.org/10.1001/jamaoncol.2018.0131 doi:10.1001/jamaoncol.2018.0131 doi:10.1001/jamaoncol.2018.0131 |
| spellingShingle | Fallon, Marie T. Wilcock, Andrew Kelly, Caroline A. Paul, James Lewsley, Liz-Anne Norrie, John Laird, Barry J. A. Oral ketamine vs placebo in patients with cancer-related neuropathic pain |
| title | Oral ketamine vs placebo in patients with cancer-related neuropathic pain |
| title_full | Oral ketamine vs placebo in patients with cancer-related neuropathic pain |
| title_fullStr | Oral ketamine vs placebo in patients with cancer-related neuropathic pain |
| title_full_unstemmed | Oral ketamine vs placebo in patients with cancer-related neuropathic pain |
| title_short | Oral ketamine vs placebo in patients with cancer-related neuropathic pain |
| title_sort | oral ketamine vs placebo in patients with cancer-related neuropathic pain |
| url | https://eprints.nottingham.ac.uk/51161/ https://eprints.nottingham.ac.uk/51161/ https://eprints.nottingham.ac.uk/51161/ |